SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for incurable germ cell tumors: cabozantinib trial underway
Disease control OngoingThis study tests the drug cabozantinib in 50 adults with germ cell tumors (like testicular or ovarian cancer) that have stopped responding to standard chemotherapy. The goal is to see if the drug can shrink tumors or keep them stable for at least 3 months. Participants take caboz…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Jun 17, 2026 02:43 UTC
-
Immunotherapy duo takes on rare tumors in major trial
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers. About 800 participants with over 50 different rare tumor types received these drugs to boost their immune system's ability to fight cancer. The goa…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug duo targets stubborn germ cell cancers
Disease control OngoingThis study tests two immunotherapy drugs, durvalumab and tremelimumab, in people whose germ cell tumors have come back or not responded to standard treatment. The goal is to see if this combination can shrink tumors or control the disease. About 30 adults with measurable tumors w…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Testicular cancer study tests stronger chemo to slash relapse risk
Disease control OngoingThis study compares two chemotherapy approaches for men with stage I seminoma testicular cancer who have a higher risk of the cancer coming back. One group gets a single course of carboplatin, the current standard, while the other gets a stronger combination of three drugs (BEP).…
Matched conditions: SEMINOMA
Phase: PHASE3 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Could less be more? new study aims to reduce treatment intensity for testicular cancer
Disease control OngoingThis study tests whether a reduced-intensity combination of chemotherapy and radiation can safely treat stage IIA or IIB seminoma, a type of testicular cancer. About 135 participants will receive a tailored, milder treatment plan to see if it can control the cancer as well as sta…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
Blood marker may predict cancer return in testicular cancer patients
Knowledge-focused OngoingThis study is testing whether a blood marker called miRNA 371 can predict if germ cell tumors (a type of cancer) will return after treatment. Researchers are collecting blood samples from 956 patients with newly diagnosed germ cell tumors and tracking their outcomes. The goal is …
Matched conditions: SEMINOMA
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC